Evidence map›Paper›PMID 32866787›Full record

ArticleInternational immunopharmacology2020

CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism.

Hera Wu, DeVon Herr, Nancie J MacIver, Jeffrey C Rathmell, Valerie A Gerriets

Open access · greenAbstract read
In one paragraph

Article in International immunopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Gastric Inflammation Impacts Serotonin Secretion in a Mouse Model ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hera WuDepartment of Basic Science, California Northstate University College of Medicine, Elk Grove, CA 95757, United States.
DeVon HerrDepartment of Basic Science, California Northstate University College of Medicine, Elk Grove, CA 95757, United States.
Nancie J MacIverDepartment of Pediatrics, Duke University School of Medicine, Durham, NC 27710, United States.
Jeffrey C RathmellDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN 37235, United States.
Valerie A GerrietsDepartment of Basic Science, California Northstate University College of Medicine, Elk Grove, CA 95757, United States. Electronic address: valerie.gerriets@cnsu.edu.
California Northstate University · USDuke University · USVanderbilt University · US

Funding

Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory diseaseR01DK105550 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey C Rathmell · 2015 to 2026
$4.7M
Mechanisms of T cell inflammation in obesity-induced type 2 diabetesR01DK106090 · NIDDK · DUKE UNIVERSITY · PI MACIVER, NANCIE · 2015 to 2019
$1.8M
NIDDK NIH HHS R01 DK105550NIDDK NIH HHS R01 DK106090
6 · The paper itself

Abstract

CD4 T cells play a major role to orchestrate the immune response. Upon activation, CD4 T cells differentiate into effector T cell (Teff) or regulatory T cell (Treg) subsets that promote or suppress the immune response, respectively. Along with these unique immunological roles, CD4 T cell subsets have specific metabolic requirements and programs that can influence the immune response. We therefore examined the metabolite levels of Teff and Treg in detail. Surprisingly, the metabolite showing the largest difference between Teff and Treg was serotonin (5-HT), revealing a potentially distinct role for serotonin in CD4 T cell function. 5-HT is well known as a neurotransmitter and recently has been recognized to play a role in the immune response; however, little is known about the immune cell type-specific expression of the serotonergic machinery and receptors. We therefore examined the serotonergic-related machinery in Teff and Treg and found differential expression of the serotonin transporter SERT and 5-HT1a and 5-HT2 receptors. We also found that Treg express tryptophan hydroxylase, which converts tryptophan to serotonin, suggesting for the first time that Treg synthesize serotonin. Our results in this study expand the potential immunomodulatory role of serotonin in CD4 T cell biology and could ultimately aid the development of novel immunomodulatory targets for treatment of autoimmune and neuropsychiatric disorders.

Indexed as

AnimalsCD4-Positive T-LymphocytesImmunomodulationMice, Inbred C57BLSerotoninSignal TransductionTryptophanSerotoninTryptophan5-HTLymphocytesRegulatory T cellsSerotoninT cellsTreg

Identifiers

PMID32866787
PMCPMC7657973
OpenAlexW3082891203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.